SEC Form 4 · accession 0001209191-16-139864
Aclaris Therapeutics, Inc. · ACRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William D. Humphries
Director
Period of report
Sep 1, 2016
Accepted (ET)
Sep 2, 2016 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $20.68 | Sep 1, 2016 | A | 10,000 | A | — | Aug 31, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option will vest and become exercisable in 36 equal monthly installments through September 1, 2019, subject to the reporting person's continuous service as of such vesting dates.